Stuart J. Wong

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis

A. Sun, Kyounghwa Bae, Elizabeth Gore et al. · Journal of Clinical Oncology · 2010 · 372 citations · Full text

Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911

Corey J. Langer, Jonathan Harris, Eric M. Horwitz et al. · Journal of Clinical Oncology · 2007 · 359 citations

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

Elizabeth Gore, Kyounghwa Bae, Stuart J. Wong et al. · Journal of Clinical Oncology · 2010 · 311 citations · Full text

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

Ezra E.W. Cohen, Darren W. Davis, Theodore Karrison et al. · The Lancet Oncology · 2009 · 271 citations · Full text

Metastatic Squamous-cell Carcinoma, Malignant Disease, Phase I/ii Study +8